Skip to main content
SpringerLink
Log in

The value of prostatic specific antigen density in the early diagnosis of prostate cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

In order to differentiate benign from malignant prostatic lesions, 42 patients were evaluated using the prostate specific antigen density (PSAD) test.

All patients were evaluated with PSA determination, digital rectal examination (DRE), transrectal ultrasonography (TRUS) and ultrasound-guided prostatic biopsies. PSA was analyzed by the I-MX ABBOT assay. PSAD was determined by dividing the serum PSA by the volume of the prostate. Prostatic biopsies identified cancer in 3 of the 42 patients (6.38%).

It is concluded that PSAD is valuable for the early diagnosis of localized prostatic carcinoma, especially when there are negative findings from DRE and/or TRUS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang, M. C., Valenzuela, C. A., Murphy, G. P., Chu, T. M.: Purification of a human prostate specific antigen.Invest. Urol., 17, 159 (1979).

    PubMed  CAS  Google Scholar 

  2. Oesterling, J. E.: Prostatic specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.J. Urol., 145, 907 (1991).

    PubMed  CAS  Google Scholar 

  3. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., Redwine, E.: Prostatic specific antigen as a serum marker for adenocarcinoma of the prostate.N. Engl. J. Med., 317, 909 (1987).

    Article  PubMed  CAS  Google Scholar 

  4. Babaian, R. J., Camps, J. L., Frangos, D. W., Ramirez, F., Tenney, D. M., Hassel, J. S., Fritsche, H. A.: Monoclonal prostate specific antigen in untreated prostate cancer: Relationship to clinical stage and grade.Cancer, 67, 2200 (1991).

    Article  PubMed  CAS  Google Scholar 

  5. Benson, M. C., Reinkaplan, Cooler, W. H.: Prostate specific antigen density: Of distinguished benign prostatic hypertrophy and prostate cancer.J. Urol., 147, 815 (1992).

    PubMed  CAS  Google Scholar 

  6. Benson, M. C., Cooler, W. H.: The use of prostatic specific antigen density to predictive value of intermediate levels of prostate specific antigen.J. Urol., 147, 817 (1992).

    PubMed  CAS  Google Scholar 

  7. Coplen, D. E.: Catalona: PSA density. Does its detection enhance of prostate cancer in men with symptoms of BPH and or digital findings of prostate enlargement?J. Urol., 145, 383a (1991).

    Google Scholar 

  8. Veneciano, Pavlica et al.: Correlation between prostate specific antigen evaluation by transrectal ultrasonography. Usefulness and prostate cancer.Eur. Urol., 18, 112 (1990).

    Google Scholar 

  9. Kane, R. A., Littrup, P. J., Babaian, R. J., Drago, J. R., Lee, F., Murphy, G. P., Mettlin, G.: The investigators of the American Cancer Society National Prostate Cancer Detection Project: Prostate specific antigen levels in 1695 men without evidence of prostate cancer.Cancer, 69, 1201 (1992).

    Article  PubMed  CAS  Google Scholar 

  10. Babaian, R. J., Mettlin, G., Kane, R. A., Murphy, G. P., Drago, J. R., Chesley, A.: The investigators of the American Cancer Society National Prostate Cancer Detection Project: The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonography.Cancer, 69, 1195 (1992).

    Article  PubMed  CAS  Google Scholar 

  11. Terris, M. K., Stamey, T. A.: Determiantion of prostate volume by transrectal ultrasound,J. Urol., 145 (5), 984 (1991).

    PubMed  CAS  Google Scholar 

  12. Rommel, F. M., Agusta, V. E., Breslin, J. A., Huffnagle, H. W., Pohl, C. E., Sieber, P. R., Stahl, C. A.: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice,J. Urol., 151 (1), 88 (1994).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Athens, Sismanoglio Hospital, Greece

    Ch. Deliveliotis, G. Louras, P. Kyriazis, A. Gyftopoulos, L. Louka & E. Alargof

Authors
  1. Ch. Deliveliotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Louras
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Kyriazis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Gyftopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Louka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Alargof
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deliveliotis, C., Louras, G., Kyriazis, P. et al. The value of prostatic specific antigen density in the early diagnosis of prostate cancer. International Urology and Nephrology 30, 305–310 (1998). https://doi.org/10.1007/BF02550314

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550314

Keywords

Search

Navigation